Evidence map›Paper›PMID 37963467›Full record

ArticleMed (New York, N.Y.)2023

The Medical Action Ontology: A tool for annotating and analyzing treatments and clinical management of human disease.

Leigh C Carmody, Michael A Gargano, Sabrina Toro, Nicole A Vasilevsky, Margaret P Adam, Hannah Blau, Lauren E Chan, David Gomez-Andres, Rita Horvath, Megan L Kraus and 16 more

Open access · hybridAbstract read
In one paragraph

Article in Med (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Current best practices and future opportunities for reproducible findings using large-scale neuroimaging in psychiatry.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 16 institutions in 5 countries.

Leigh C CarmodyThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Michael A GarganoThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Sabrina ToroUniversity of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Nicole A VasilevskyCritical Path Institute, Tucson, AZ, USA.
Margaret P AdamUniversity of Washington School of Medicine, Seattle, WA, USA.
Hannah BlauThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Lauren E ChanOregon State University, Corvallis, OR, USA.
David Gomez-AndresPediatric Neurology, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Rita HorvathDepartment of Clinical Neurosciences, University of Cambridge, Robinson Way, Cambridge CB2 0PY, UK.
Megan L KrausUniversity of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Markus S LadewigDepartment of Ophthalmology, Klinikum Saarbrücken, Saarbrücken, Germany.
David Lewis-SmithTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Hanns LochmüllerChildren's Hospital of Eastern Ontario Research Institute, Ottowa, Canada; Division of Neurology, Department of Medicine, The Ottawa Hospital, Ottawa, Canada; Brain and Mind Research Institute, University of Ottawa, Ottawa, Canada; Department of Neuropediatrics and Muscle Disorders, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany; Centro Nacional de Análisis Genómico, Barcelona, Spain.
Nicolas A MatentzogluSemanticly, Athens, Attiki, Greece.
Monica C Munoz-TorresUniversity of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Catharina SchuetzDepartment of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.
Berthold SeitzDepartment of Ophthalmology, Saarland University Medical Center UKS, Homburg, Saar, Germany.
Morgan N SimilukNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Teresa N SparksDepartment of Obstetrics, Gynecology, & Reproductive Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Timmy StraussDepartment of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.
Emilia M SwietlikDepartment of Medicine, University of Cambridge, Heart and Lung Research Institute, Cambridge CB2 0BB, UK.
Rachel ThompsonChildren's Hospital of Eastern Ontario Research Institute, Ottowa, Canada.
Xingmin Aaron ZhangThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Christopher J MungallLawrence Berkeley National Laboratory, Berkeley, CA, USA.
Melissa A HaendelUniversity of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Peter N RobinsonThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. Electronic address: peter.robinson@jax.org.
Jackson Laboratory · USUniversity of Colorado Anschutz Medical Campus · USUniversity Hospital Carl Gustav Carus · DEUniversity of Cambridge · GBChildren's Hospital of Eastern Ontario · CACritical Path Institute · USKlinikum Saarbrücken · DELawrence Berkeley National Laboratory · USNational Institutes of Health · USNewcastle University · GBOregon State University · USSaarland University · DEUniversity of California, San Francisco · USUniversity of Ottawa · CAUniversity of Washington · USVall d'Hebron Institut de Recerca · ES

Funding

Improvements to the LinkML framework to support the Phenomics First open science resourceRM1HG010860 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAENDEL, MELISSA A, MUNGALL, CHRISTOPHER J · 2020 to 2024
$10.3M
The Human Phenotype Ontology: Accelerating Computational Integration of Clinical Data for GenomicsU24HG011449 · NHGRI · JACKSON LABORATORY · PI Peter Nicholas Robinson · 2021 to 2026
$6.7M
Medical Research Council MR/S005021/1Medical Research Council MR/V009346/1NHGRI NIH HHS RM1 HG010860NHGRI NIH HHS U24 HG011449
6 · The paper itself

Abstract

backgroundNavigating the clinical literature to determine the optimal clinical management for rare diseases presents significant challenges. We introduce the Medical Action Ontology (MAxO), an ontology specifically designed to organize medical procedures, therapies, and interventions.

methodsMAxO incorporates logical structures that link MAxO terms to numerous other ontologies within the OBO Foundry. Term development involves a blend of manual and semi-automated processes. Additionally, we have generated annotations detailing diagnostic modalities for specific phenotypic abnormalities defined by the Human Phenotype Ontology (HPO). We introduce a web application, POET, that facilitates MAxO annotations for specific medical actions for diseases using the Mondo Disease Ontology.

findingsMAxO encompasses 1,757 terms spanning a wide range of biomedical domains, from human anatomy and investigations to the chemical and protein entities involved in biological processes. These terms annotate phenotypic features associated with specific disease (using HPO and Mondo). Presently, there are over 16,000 MAxO diagnostic annotations that target HPO terms. Through POET, we have created 413 MAxO annotations specifying treatments for 189 rare diseases.

conclusionsMAxO offers a computational representation of treatments and other actions taken for the clinical management of patients. Its development is closely coupled to Mondo and HPO, broadening the scope of our computational modeling of diseases and phenotypic features. We invite the community to contribute disease annotations using POET (https://poet.jax.org/). MAxO is available under the open-source CC-BY 4.0 license (https://github.com/monarch-initiative/MAxO).

fundingNHGRI 1U24HG011449-01A1 and NHGRI 5RM1HG010860-04.

Indexed as

Biological OntologiesComputer SimulationHumansRare DiseasesSoftwareclinical managementcomputational decision supportFoundational researchMAxOmedical action ontologyontologysurgical proceduretreatment

Identifiers

PMID37963467
PMCPMC10842845
OpenAlexW4388639867

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.